<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-02-29">29 February 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Karin</forename><surname>Kast</surname></persName>
							<email>karin.kast@uniklinikum-dresden.de</email>
							<affiliation key="aff2">
								<orgName type="department">Department of Gynecology and Obstetrics</orgName>
								<orgName type="institution">University Hospital Carl Gustav Carus, TU Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ)</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kerstin</forename><surname>Rhiem</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Center for Hereditary Breast and Ovarian Cancer</orgName>
								<orgName type="department" key="dep2">Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC)</orgName>
								<orgName type="department" key="dep3">Medical Faculty</orgName>
								<orgName type="institution">University of Cologne and University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Barbara</forename><surname>Wappenschmidt</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Center for Hereditary Breast and Ovarian Cancer</orgName>
								<orgName type="department" key="dep2">Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC)</orgName>
								<orgName type="department" key="dep3">Medical Faculty</orgName>
								<orgName type="institution">University of Cologne and University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eric</forename><surname>Hahnen</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Center for Hereditary Breast and Ovarian Cancer</orgName>
								<orgName type="department" key="dep2">Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC)</orgName>
								<orgName type="department" key="dep3">Medical Faculty</orgName>
								<orgName type="institution">University of Cologne and University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jan</forename><surname>Hauke</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Center for Hereditary Breast and Ovarian Cancer</orgName>
								<orgName type="department" key="dep2">Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC)</orgName>
								<orgName type="department" key="dep3">Medical Faculty</orgName>
								<orgName type="institution">University of Cologne and University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Britta</forename><surname>Bluemcke</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Center for Hereditary Breast and Ovarian Cancer</orgName>
								<orgName type="department" key="dep2">Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC)</orgName>
								<orgName type="department" key="dep3">Medical Faculty</orgName>
								<orgName type="institution">University of Cologne and University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Verena</forename><surname>Zarghooni</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Center for Hereditary Breast and Ovarian Cancer</orgName>
								<orgName type="department" key="dep2">Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC)</orgName>
								<orgName type="department" key="dep3">Medical Faculty</orgName>
								<orgName type="institution">University of Cologne and University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Natalie</forename><surname>Herold</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Center for Hereditary Breast and Ovarian Cancer</orgName>
								<orgName type="department" key="dep2">Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC)</orgName>
								<orgName type="department" key="dep3">Medical Faculty</orgName>
								<orgName type="institution">University of Cologne and University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nina</forename><surname>Ditsch</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department for Gynecology and Obstetrics</orgName>
								<orgName type="institution">LMU Munich</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marion</forename><surname>Kiechle</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department for Gynecology and Obstetrics</orgName>
								<orgName type="institution">Technical University of Munich</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Braun</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Breast Center</orgName>
								<orgName type="department" key="dep2">Department of Gynecology</orgName>
								<orgName type="institution">Red Cross Hospital</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christine</forename><surname>Fischer</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">Heidelberg University</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicola</forename><surname>Dikow</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">Heidelberg University</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sarah</forename><surname>Schott</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Department of Gynecology and Obstetrics</orgName>
								<orgName type="institution">Heidelberg University Hospital</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">German Cancer Consortium (DKTK)</orgName>
								<orgName type="institution">NCT Heidelberg and German Cancer Research Center (DKFZ)</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nils</forename><surname>Rahner</surname></persName>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">Medical Faculty</orgName>
								<orgName type="department" key="dep2">Institute of Human Genetics and Anthropology</orgName>
								<orgName type="institution">Heinrich-Heine University</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dieter</forename><surname>Niederacher</surname></persName>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Department of Gynecology and Obstetrics</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">Heinrich-Heine University</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tanja</forename><surname>Fehm</surname></persName>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Department of Gynecology and Obstetrics</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">Heinrich-Heine University</orgName>
								<address>
									<settlement>Düsseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Gehrig</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Department of Human Genetics</orgName>
								<orgName type="institution">University of Wuerzburg</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Clemens</forename><surname>Mueller-Reible</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Department of Human Genetics</orgName>
								<orgName type="institution">University of Wuerzburg</orgName>
								<address>
									<settlement>Würzburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Norbert</forename><surname>Arnold</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="institution">University Hospital of Schleswig-Holstein</orgName>
								<address>
									<addrLine>Campus Kiel</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff15">
								<orgName type="institution">Christian-Albrechts University Kiel</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicolai</forename><surname>Maass</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="institution">University Hospital of Schleswig-Holstein</orgName>
								<address>
									<addrLine>Campus Kiel</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff15">
								<orgName type="institution">Christian-Albrechts University Kiel</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Guntram</forename><surname>Borck</surname></persName>
							<affiliation key="aff16">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">University of Ulm</orgName>
								<address>
									<settlement>Ulm</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nikolaus</forename><surname>De Gregorio</surname></persName>
							<affiliation key="aff17">
								<orgName type="department">Department of Gynecology and Obstetrics</orgName>
								<orgName type="institution" key="instit1">University Hospital</orgName>
								<orgName type="institution" key="instit2">Universität Ulm</orgName>
								<address>
									<settlement>Ulm</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Caroline</forename><surname>Scholz</surname></persName>
							<affiliation key="aff18">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bernd</forename><surname>Auber</surname></persName>
							<affiliation key="aff18">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Raymonda</forename><surname>Varon-Manteeva</surname></persName>
							<affiliation key="aff19">
								<orgName type="department">Institute of Medical and Human Genetics</orgName>
								<orgName type="institution">Charite-University Medical Center</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dorothee</forename><surname>Speiser</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Department of Gynecology</orgName>
								<orgName type="institution">Charité University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Judit</forename><surname>Horvath</surname></persName>
							<affiliation key="aff21">
								<orgName type="department">Institute for Human Genetics</orgName>
								<orgName type="institution">University of Muenster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nadine</forename><surname>Lichey</surname></persName>
							<affiliation key="aff21">
								<orgName type="department">Institute for Human Genetics</orgName>
								<orgName type="institution">University of Muenster</orgName>
								<address>
									<settlement>Münster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Pauline</forename><surname>Wimberger</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Gynecology and Obstetrics</orgName>
								<orgName type="institution">University Hospital Carl Gustav Carus, TU Dresden</orgName>
								<address>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ)</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sylvia</forename><surname>Stark</surname></persName>
							<affiliation key="aff22">
								<orgName type="department">Department of Gynecology and Obstetrics</orgName>
								<orgName type="institution">University of Leipzig</orgName>
								<address>
									<settlement>Leipzig</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ulrike</forename><surname>Faust</surname></persName>
							<affiliation key="aff23">
								<orgName type="department">Institute of Medical Genetics and Applied Genomics</orgName>
								<orgName type="institution">University of Tuebingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bernhard</forename><forename type="middle">H F</forename><surname>Weber</surname></persName>
							<affiliation key="aff24">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">University of Regensburg</orgName>
								<address>
									<settlement>Regensburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gunter</forename><surname>Emons</surname></persName>
							<affiliation key="aff25">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Göttingen</orgName>
								<address>
									<settlement>Göttingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Silke</forename><surname>Zachariae</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC)</orgName>
							</affiliation>
							<affiliation key="aff26">
								<orgName type="department">Institute for Medical Informatics, Statistics and Epidemiology</orgName>
								<orgName type="institution">University of Leipzig</orgName>
								<address>
									<settlement>Leipzig</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alfons</forename><surname>Meindl</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department for Gynecology and Obstetrics</orgName>
								<orgName type="institution">Technical University of Munich</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rita</forename><forename type="middle">K</forename><surname>Schmutzler</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Center for Hereditary Breast and Ovarian Cancer</orgName>
								<orgName type="department" key="dep2">Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC)</orgName>
								<orgName type="department" key="dep3">Medical Faculty</orgName>
								<orgName type="institution">University of Cologne and University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christoph</forename><surname>Engel</surname></persName>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Department of Gynecology and Obstetrics</orgName>
								<orgName type="institution">University Hospital Carl Gustav Carus, TU Dresden</orgName>
								<address>
									<addrLine>Fetscherstraße 74</addrLine>
									<postCode>01069</postCode>
									<settlement>Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-02-29">29 February 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">B567080C66B835E133AF7B8ABA669F13</idno>
					<idno type="DOI">10.1136/jmedgenet-2015-103672</idno>
					<note type="submission">Received 28 November 2015 Revised 21 January 2016 Accepted 2 February 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:18+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>For numbered affiliations see end of article.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Women with pathogenic germline mutations in the BRCA1 and BRCA2 genes are at an increased lifetime risk for breast cancer (BC) and ovarian cancer (OC) compared with the general population. <ref type="bibr" target="#b0">1</ref> Identification of mutation carriers is an important prerequisite for targeted clinical management.</s><s>7]<ref type="bibr" target="#b7">[8]</ref> Consequently, to define appropriate clinical selection criteria, precise knowledge on expected mutation frequencies for individual family histories is required.</s><s>]<ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref> In the largest study so far, Frank et al <ref type="bibr" target="#b10">11</ref> correlated familial disease histories of 10 000 consecutively enrolled individuals with mutation status, resulting in detailed tabulations of empiric mutation prevalences.</s></p><p><s>In 1996, the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC) had established a panel of clinical criteria for genetic testing of individuals in a clinical setting, based on familial BC and OC history. <ref type="bibr" target="#b6">7</ref></s><s>By the end of 2014, a total of 21 401 families suspected of having a deleterious BRCA mutation according to this panel of clinical criteria were enrolled into the central registry of GC-HBOC.</s><s>Based on this data set, we aimed to comprehensively analyse the correlation of family history of BC and OC with BRCA mutation frequencies.</s><s>We were particularly interested in the predictive value of the number of premenopausal versus postmenopausal BCs in the family, and the presence of premenopausal or postmenopausal bilateral breast cancer (bBC) versus unilateral cancer.</s><s>With this analysis, we aim to provide guidance for counsellors, counselees and decisionmakers on the offer and uptake of genetic testing.</s><s>families with clustering or early onset of BC or OC are registered and tested for the presence of deleterious germline mutations in BRCA1 and BRCA2.</s><s>Comprehensive data on familial cancer history, including a detailed pedigree, pathology reports and results of molecular testing, are documented in a central database using standardised electronic case report forms.</s></p><p><s>A total number of 21 401 families, who were registered from 1996 until 2014, were included in the present analysis.</s><s>All families fulfilled the clinical inclusion criteria shown in table <ref type="table" target="#tab_1">2</ref>. Families who were ascertained through a known pathogenic mutation rather than by clinical criteria were not included.</s><s>If possible, the family member with the most severe phenotype (defined as bBC, BC and OC, or earliest age of onset) was chosen as the index patient and was searched for BRCA1 and BRCA2 mutations.</s><s>In case that no DNA from an affected family member could be obtained, mutation analysis was performed in unaffected individuals.</s><s>BC included ductal carcinoma in situ.</s><s>OC included cancers of the fallopian tube and primary peritoneal cancers irrespective of histopathological subtype and grading.</s><s>BC cases with an age of onset of 50 years or earlier are hereafter referred to as premenopausal BC (BC 50− ).</s><s>BC at the age from 51 years onwards are referred to as postmenopausal BC (BC 51+ ).</s><s>For bBC, the age of onset of the first cancer was considered.</s><s>The present study did not include families with single cases of OC or single cases of male breast cancer (mBC) since these families were not part of the clinical inclusion criteria.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mutation analysis</head><p><s>Mutation analysis was performed using direct sequencing or a pre-screening step followed by direct sequencing of suspect fragments.</s><s>Pre-screening methods comprised mainly denaturing high-performance liquid chromatography and high-resolution melting. <ref type="bibr">15 16</ref></s><s>Before the year 1999, single-strand conformation polymorphism and protein truncation test were used.</s><s>If no deleterious sequence alterations were found in these steps, an additional screening for large genomic alterations was performed using multiplex ligation-dependent probe amplification.</s><s>In the present study, 88.4% of all BRCA1/2-negative index patients were searched for large genomic alterations.</s><s><ref type="bibr" target="#b18">[19]</ref> Statistical analysis IBM SPSS 22 was used for statistical analysis.</s><s>The 95% CIs for mutation frequencies were calculated using Wilson's score  The families were classified into seven mutually exclusive groups of aggregated familial cancer histories (table <ref type="table" target="#tab_1">2</ref>).</s><s>These groups cover the inclusion criteria of the GC-HBOC established in 1996.</s><s>The overall BRCA1/2 mutation prevalence was 24.0% (95% CI 23.4% to 24.6%).</s><s>The highest mutation frequencies were seen in families with at least two OC (41.9%, 95% CI 36.1% to 48.0%) and families with at least one BC and one OC (41.6%, 95% CI 40.3% to 43.0%) followed by families with mBC and at least one additional female with BC or OC (35.8%, 95% CI 32.2% to 39.6%).</s><s>BRCA1 mutations were more frequent in families with OC, whereas BRCA2 mutations were more frequent in families with mBC.</s><s>The largest group comprises families with at least two cases of BC, at least one that was diagnosed before the age of 51 (n=12.996,</s><s>60.7% of all families).</s><s>The lowest mutation frequencies (3.7%, 95% CI 2.5% to 5.3%) were observed in families with three or more cases of postmenopausal BC, but no occurrence of premenopausal BC, OC or male BC.</s></p><p><s>To characterise mutation frequencies in more detail, the familial cancer histories were further refined.</s><s>Table <ref type="table" target="#tab_3">3</ref> shows the mutation prevalences in families, in which exclusively female BC was present (72.1% of all families).</s><s>Group 1a comprises families with exclusive occurrence of unilateral cases of BC (53.1% of all families), whereas groups 1b (14.6%) and 1c ).</s><s>In all subgroups, the occurrence of additional cases of postmenopausal BC did not considerably change mutation frequencies.</s><s>In contrast, additional cases of premenopausal BC increased the mutation frequencies considerably.</s><s>Table <ref type="table" target="#tab_4">4</ref> lists families with OC only (group 2a, 1.2% of all families), families with BC and OC (group 2b, 23.7%) and families with occurrence of mBC (group 3, 3.0%).</s><s>In families with one case of BC and one case of OC, mutation frequencies were considerably higher when the BC case was premenopausal (31.5% 95% CI 28.0% to 35.2% vs 19.2%, 95% CI 15.3% to 23.8%).</s><s>Double primary premenopausal BC and OC in one individual was associated with a much higher mutation prevalence than the occurrence of premenopausal BC and OC in two different women (49.0%, 95% CI 41.0% to 57.0% vs 31.5%,</s><s>95% CI 28.0% to 35.2, p&lt;0.001).</s><s>However, there was no significant difference in mutation prevalence between double primary BC and OC (BCOC) and occurrence of BC and OC in two different women (BC/OC) when the BC was postmenopausal instead of premenopausal (20.3%, 95% CI 14.1% to 28.5% vs 19.2%, 95% CI 15.3% to 23.8, p=0.788).</s></p><p><s>In families with mBC (table 4, group 3) and an additional case of female BC, no significant difference in mutation frequencies could be detected depending on menopausal status of the BC (16.5%, 95% CI 10.4% to 25.1% vs 23.2%, 95% CI 16.0% to 32.5%, p=0.284).</s><s>In families with mBC and additional cases of OC, mutation frequencies for BRCA1 and BRCA2 mutations were similar in contrast to families without additional OC cases.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Based on a large sample of 21 401 families, the present study provides a detailed characterisation of BRCA1/2 mutation prevalences for defined patterns of familial BC and OC.</s><s>The underlying data were collected over a period of almost 20 years (1996-2015) in a standardised way within a German multicentre consortium of interdisciplinary university centres specialised in providing healthcare for families with HBOC.</s><s>All families suspected of having HBOC were selected for genetic testing according to a set of defined clinical criteria that were compulsory for all participating centres.</s></p><p><s>The German HBOC consortium has defined inclusion criteria for BRCA1/2 testing based on at least three generation pedigree analysis. <ref type="bibr" target="#b5">6</ref></s><s>Currently, GC-HBOC offers genetic testing to index patients if the expected BRCA mutation probability is ≥10% based on the individual family cancer history.</s><s>In our study, the overall mutation prevalence was 24.0%.</s><s>The decision threshold of 10% is exceeded in almost all subgroups of HBOC families including mBC.</s><s>However, families with exclusive occurrence of three or more postmenopausal BC cases (3.2% of all families) were below the 10% threshold with a mutation of prevalence of only 3.7%.</s><s>The latter finding is in line with the study of Frank et al, <ref type="bibr" target="#b10">11</ref> who reported a prevalence of 3.9%.</s><s>Interestingly, the low prevalence observed in our study was independent of whether bilateral cases were present among the postmenopausal BCs in the family (3.1%) or not (3.8%).</s><s>Moreover, mutation prevalences did not increase with the number of postmenopausal BC cases in the family.</s><s>On the contrary, in a previous study we showed that an increasing number of females with BC diagnosed at an age of 60 or later was associated with a decreasing BRCA1/2 mutation frequency. <ref type="bibr" target="#b19">20</ref></s><s>n contrast to postmenopausal BC, mutation prevalence increased considerably with each additional case of premenopausal BC both in families with exclusive occurrence of BC and in families with BC and OC.</s><s>This agrees well with the results of the study of Frank et al. <ref type="bibr" target="#b10">11</ref> In our study, mutation prevalence was even higher if at least one case of premenopausal BC was bilateral.</s><s>In contrast, the presence of postmenopausal bilateral BC did not increase the chance to detect a deleterious mutation.</s><s>This observation is in line with a previous study of Gershoni-Baruch et al, <ref type="bibr" target="#b20">21</ref> who suggested that bBC per se is not reflective of genetic predisposition, unless associated with early age of onset.</s><s>However, other studies came to the conclusion that mutation frequencies are similar if two cancers (bBC or BCOC) occurred in one individual compared with two separate individuals. <ref type="bibr">10 22-24</ref></s><s>In our study, mutations were detected significantly more often in families with a single case of premenopausal bilateral BC than in families with two independent premenopausal BC (22.7% vs 17.5%, p=0.012).</s></p><p><s>In accordance with other studies, the highest mutation rates were observed in families with BC and OC. <ref type="bibr">4 9 11 12</ref> As observed in families with exclusive occurrence of BC, mutation prevalence was considerably higher if BC cases were premenopausal.</s><s>Moreover, mutation prevalence was significantly higher in individuals with double primaries of ovarian and premenopausal BC than if these two cancers occurred in different women.</s></p><p><s>Our study comprised 642 families with mBC.</s><s>Due to the inclusion criteria, these families had at least one additional case of female BC or OC.</s><s>As described in previous studies, BRCA2 mutations were found more frequently than BRCA1 mutations in families with mBC but without occurrence of OC.</s><s>In cases where additional OC cases were present in these families, a similar prevalence of mutations was found in BRCA1 and BRCA2.</s><s>The additional presence of a premenopausal versus postmenopausal BC increased the mutation prevalence from 16.5% to 23.2%, although this difference was not significant due to low sample sizes in these groups.</s></p><p><s>The present study revealed a mutation prevalence of 13.7% (9.2%, 95% CI 7.7% to 10.9% for BRCA1 and 4.5%, 95% CI 3.5% to 5.8% for BRCA2) for individuals with early unilateral BC before the age of 36 years without further cancer cases in their family.</s><s>This is in line with results from two other studies. <ref type="bibr">25 26</ref></s><s>However, there is evidence in the literature that the prevalence of BRCA1 and BRCA2 mutations is high in women with triple-negative breast cancer (TNBC) and that BRCA1/2 mutations are not restricted to young women or patients with a positive family history. <ref type="bibr" target="#b26">27</ref></s><s>Thus, single cases of TNBC might be considered in BRCA1/2 genetic testing guidelines with an extended age of onset that requires further exploration to confirm a potential cut-off at the age of 60 years as suggested by the data of Couch et al. <ref type="bibr" target="#b26">27</ref> Comparison of our data to empiric mutation frequencies of other groups is difficult due to varying inclusion criteria.</s><s>For example, in high-risk HBOC families of Czech ancestry an overall detection rate of 29% was reported compared with 24.0% by us. <ref type="bibr" target="#b11">12</ref></s><s>That work was restricted to first-degree and second-degree relatives in the maternal line and to third-degree relatives in the case of paternal transmission.</s><s>In the work of Frank et al, <ref type="bibr" target="#b10">11</ref> the overall detection frequency was 15.7% in non-Ashkenazi individuals, but postmenopausal BC was not taken into account.</s></p><p><s>Some limitations have to be mentioned.</s><s>First, in our study only aggregated familial cancer histories were correlated with mutation prevalence, that is, the pedigree size and family structure was not considered.</s><s>3]<ref type="bibr" target="#b33">[34]</ref> In our study, we did not restrict the analysis to OC with specific pathological features since pathology information was not available for all OC.</s><s>Thus, we cannot exclude that a restriction to this specific type of OC would have led to larger mutation frequencies.</s></p><p><s>In summary, we provide a detailed overview on empiric BRCA1/2 mutation frequencies for at-risk individuals with different familial cancer histories.</s><s>The number of postmenopausal BC failed to show a systematic correlation with mutation frequency.</s><s>Bilateral BC or premenopausal BC and OC in one affected family member conferred a higher mutation prevalence than two primaries in separate individuals.</s><s>Our analysis provides a simple means to get an overview about expected mutation probabilities during clinical and genetic counselling before mutation testing is considered for both counsellors and counselees.</s><s>Moreover, our results provide guidance for healthcare professionals and decision-makers to define consistent clinical criteria for decision-making to undergo genetic testing for individuals with suspected HBOC.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Family characteristics</s></p></div></figDesc><table><row><cell></cell><cell>Total</cell><cell>BRCA1</cell><cell>BRCA2</cell><cell>Negative</cell></row><row><cell>Families, no</cell><cell>21 401</cell><cell>3398</cell><cell>1766</cell><cell>16 265</cell></row><row><cell>Members</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Total number</cell><cell>617 578</cell><cell>99 708</cell><cell>52 861</cell><cell>466 013</cell></row><row><cell>Median per family</cell><cell>25</cell><cell>26</cell><cell>26</cell><cell>25</cell></row><row><cell>Members with cancer, no</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>uBC 50−</cell><cell>26 236</cell><cell>4996</cell><cell>2519</cell><cell>18 770</cell></row><row><cell>uBC 51+</cell><cell>24 452</cell><cell>2789</cell><cell>2033</cell><cell>19 655</cell></row><row><cell>bBC 50−</cell><cell>4132</cell><cell>1304</cell><cell>427</cell><cell>2414</cell></row><row><cell>bBC 51+</cell><cell>1896</cell><cell>239</cell><cell>168</cell><cell>1492</cell></row><row><cell>OC</cell><cell>7250</cell><cell>2650</cell><cell>730</cell><cell>3897</cell></row><row><cell>BC and OC</cell><cell>1917</cell><cell>805</cell><cell>202</cell><cell>916</cell></row><row><cell>Male BC</cell><cell>671</cell><cell>62</cell><cell>193</cell><cell>420</cell></row><row><cell>Age of onset (mean)*</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>BC</cell><cell>49.0</cell><cell>44.4</cell><cell>47.5</cell><cell>50.2</cell></row><row><cell>OC</cell><cell>51.5</cell><cell>49.8</cell><cell>55.6</cell><cell>51.9</cell></row><row><cell>Male BC</cell><cell>58.0</cell><cell>56.9</cell><cell>60.4</cell><cell>57.0</cell></row><row><cell cols="5">*Mean ages of onset for BC and OC were significantly different in all pairwise group</cell></row><row><cell cols="5">comparisons (p&lt;0.001). For male BC, mean age of onset was significantly different</cell></row><row><cell cols="4">between BRCA2-positive and BRCA1/2-negative families (p=0.006).</cell><cell></cell></row><row><cell cols="4">bBC, bilateral breast cancer; BC, breast cancer; OC, ovarian cancer.</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Familial breast and ovarian cancer histories used as inclusion criteria for BRCA1/2 mutation testing in German Consortium for Hereditary Breast and Ovarian Cancer and observed mutation prevalences</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell cols="3">Families with pathogenic mutation</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Families</cell><cell></cell><cell cols="2">BRCA1/2</cell><cell></cell><cell>BRCA1</cell><cell></cell><cell></cell><cell>BRCA2</cell><cell></cell><cell></cell></row><row><cell>Distinct groups of familial BC and</cell><cell></cell><cell>% of</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>OC history (including proband)</cell><cell>N</cell><cell cols="2">total n</cell><cell>Prev (%)</cell><cell cols="2">95% CI (%) n</cell><cell>Prev (%)</cell><cell cols="2">95% CI (%) n</cell><cell>Prev (%)</cell><cell>95% CI (%)</cell></row><row><cell>Total</cell><cell cols="3">21 401 100.0 5136</cell><cell>24.0</cell><cell cols="2">23.4 to 24.6 3398</cell><cell>15.9</cell><cell cols="2">15.4 to 16.4 1766</cell><cell>8.3</cell><cell>7.9 to 8.6</cell></row><row><cell>≥3 females with BC 51+ (no BC&lt;51, no</cell><cell>684</cell><cell>3.2</cell><cell>25</cell><cell>3.7</cell><cell>2.5 to 5.3</cell><cell>9</cell><cell>1.3</cell><cell>0.7 to 2.5</cell><cell>17</cell><cell>2.5</cell><cell>1.6 to 3.9</cell></row><row><cell>OC, no mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>≥2 females with BC, of these ≥1 with</cell><cell>12 996</cell><cell cols="2">60.7 2379</cell><cell>18.3</cell><cell cols="2">17.7 to 19.0 1439</cell><cell>11.1</cell><cell>10.5 to 11.6</cell><cell>949</cell><cell>7.3</cell><cell>6.9 to 7.8</cell></row><row><cell>BC 50− (no OC, no mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Single female with unilateral</cell><cell>1267</cell><cell>5.9</cell><cell>173</cell><cell>13.7</cell><cell>11.9 to 15.7</cell><cell>116</cell><cell>9.2</cell><cell>7.7 to 10.9</cell><cell>57</cell><cell>4.5</cell><cell>3.5 to 5.8</cell></row><row><cell>BC 35− (no further female BC, no OC,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>no mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Single female with bBC 50− (no further</cell><cell>480</cell><cell>2.2</cell><cell>109</cell><cell>22.7</cell><cell>19.2 to 26.7</cell><cell>73</cell><cell>15.2</cell><cell>12.3 to 18.7</cell><cell>36</cell><cell>7.5</cell><cell>5.5 to 10.2</cell></row><row><cell>female BC, no OC, no mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>≥1 females with BC and ≥1 female</cell><cell>5072</cell><cell cols="2">23.7 2111</cell><cell>41.6</cell><cell cols="2">40.3 to 43.0 1624</cell><cell>32.0</cell><cell>30.7 to 33.3</cell><cell>500</cell><cell>9.9</cell><cell>9.1 to 10.7</cell></row><row><cell>with OC (no mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>≥2 females with OC (no female BC,</cell><cell>260</cell><cell>1.2</cell><cell>109</cell><cell>41.9</cell><cell>36.1 to 48.0</cell><cell>77</cell><cell>29.6</cell><cell>24.4 to 35.4</cell><cell>34</cell><cell>13.1</cell><cell>9.5 to 17.7</cell></row><row><cell>no mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>≥1 male with BC and ≥1 females with BC or OC method.For comparison of mutation frequencies between groups, the χ 2 test was used.pValues</s><s>&lt;0.05 were considered significant.RESULTSBasic characteristics of the study population are summarised in</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>table 1 .</head><label>1</label><figDesc><div><p><s>Of 21 401 families, 3398 (15.9%) had a pathogenic mutation in BRCA1 and 1766 (8.3%) in BRCA2.</s><s>Of these, 28 families had mutations in both genes, BRCA1 and BRCA2.</s><s>The median number of family members documented in each pedigree was 25, regardless of BRCA mutation status.</s><s>The mean age at cancer diagnosis was 44.4 years for BC and 49.8 years for OC in BRCA1-positive families compared with 47.5 and 55.6 years, in BRCA2-positive families, and 50.2 and 51.9 years in BRCA-negative families.</s><s>The mean age at diagnosis of mBC in BRCA1-positive families was 56.9 years, which was younger than in BRCA2 mutation carriers (60.4 years) and equal to BRCA1/2-negative families (57.0 years).</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3</head><label>3</label><figDesc><div><p><s>BRCA mutation prevalence in families with female breast cancer only</s></p></div></figDesc><table><row><cell>Families with pathogenic mutation</cell></row></table><note><p><s>*≤35 years.</s><s>bBC, bilateral breast cancer; BC, breast cancer; mBC, male breast cancer; OC, ovarian cancer; Prev, prevalence.</s><s>Kast K, et al.</s><s>J Med Genet 2016;53:465-471.</s><s>doi:10.1136/jmedgenet-2015-103672</s><s>467</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4</head><label>4</label><figDesc><div><p><s>BRCA mutation prevalence in families with ovarian cancer (OC) only (group 2a), both breast cancer (BC) and OC (group 2b), and male breast cancer (mBC) (group 3)</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="4">Families with pathogenic mutation</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell cols="2">Families</cell><cell cols="2">BRCA1/2</cell><cell></cell><cell>BRCA1</cell><cell></cell><cell></cell><cell cols="2">BRCA2</cell><cell></cell></row><row><cell></cell><cell>Familial cancer history</cell><cell></cell><cell>% of</cell><cell></cell><cell>Prev</cell><cell></cell><cell></cell><cell>Prev</cell><cell></cell><cell></cell><cell>Prev</cell><cell></cell></row><row><cell>Group</cell><cell>(including proband)</cell><cell>N</cell><cell>total</cell><cell>n</cell><cell>(%)</cell><cell>95% CI (%)</cell><cell>n</cell><cell>(%)</cell><cell>95% CI (%)</cell><cell>n</cell><cell>(%)</cell><cell>95% CI (%)</cell></row><row><cell>Group 2a:</cell><cell>2 OC</cell><cell>194</cell><cell>0.9</cell><cell></cell><cell>79 40.7</cell><cell>34.1 to 47.8</cell><cell cols="2">50 25.8</cell><cell>20.1 to 32.4</cell><cell cols="2">29 14.9</cell><cell>10.6 to 20.6</cell></row><row><cell>OC only</cell><cell>(no BC, mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>≥3 OC</cell><cell>66</cell><cell>0.3</cell><cell></cell><cell>30 45.5</cell><cell>34.0 to 57.4</cell><cell cols="2">27 40.9</cell><cell>29.9 to 53.0</cell><cell>5</cell><cell>7.6</cell><cell>3.3 to 16.5</cell></row><row><cell></cell><cell>(no BC, mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Total</cell><cell>260</cell><cell>1.2</cell><cell></cell><cell>109 41.9</cell><cell>36.1 to 48.0</cell><cell cols="2">77 29.6</cell><cell>24.4 to 35.4</cell><cell cols="2">34 13.1</cell><cell>9.5 to 17.7</cell></row><row><cell>Group 2b: OC and</cell><cell>1 BC 51+ OC</cell><cell>118</cell><cell>0.6</cell><cell></cell><cell>24 20.3</cell><cell>14.1 to 28.5</cell><cell cols="2">17 14.4</cell><cell>9.2 to 21.9</cell><cell>7</cell><cell>5.9</cell><cell>2.9 to 11.7</cell></row><row><cell>female BC,</cell><cell>(no mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>but no mBC</cell><cell>1 BC 50− OC</cell><cell>145</cell><cell>0.7</cell><cell></cell><cell>71 49.0</cell><cell>41.0 to 57.0</cell><cell cols="2">56 38.6</cell><cell>31.1 to 46.7</cell><cell cols="2">15 10.3</cell><cell>6.4 to 16.4</cell></row><row><cell></cell><cell>(no mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>≥2 BCOC</cell><cell>11</cell><cell>0.1</cell><cell></cell><cell>7 63.6</cell><cell>35.4 to 84.8</cell><cell cols="2">7 63.6</cell><cell>35.4 to 84.8</cell><cell>0</cell><cell>0.0</cell><cell>0.0 to 25.9</cell></row><row><cell></cell><cell>(no mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>≥2 BCOC+≥1</cell><cell>1482</cell><cell>6.9</cell><cell></cell><cell>796 53.7</cell><cell>51.2 to 56.2</cell><cell cols="2">641 43.3</cell><cell>40.8 to 45.8</cell><cell cols="2">160 10.8</cell><cell>9.3 to 12.5</cell></row><row><cell></cell><cell>BC/OC (no mBC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>1 BC 51+ +1 OC</cell><cell>333</cell><cell>1.6</cell><cell></cell><cell>64 19.2</cell><cell>15.3 to 23.8</cell><cell cols="2">39 11.7</cell><cell>8.7 to 15.6</cell><cell>26</cell><cell>7.8</cell><cell>5.4 to 11.2</cell></row><row><cell></cell><cell>(no mBC, BCOC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>1 BC 50− +1 OC</cell><cell>645</cell><cell>3.0</cell><cell></cell><cell>203 31.5</cell><cell>28.0 to 35.2</cell><cell cols="2">155 24.0</cell><cell>20.9 to 27.5</cell><cell>48</cell><cell>7.4</cell><cell>5.7 to 9.7</cell></row><row><cell></cell><cell>(no mBC, BCOC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>1 BC+≥2 OC</cell><cell>248</cell><cell>1.2</cell><cell></cell><cell>113 45.6</cell><cell>39.5 to 51.8</cell><cell cols="2">100 40.3</cell><cell>34.4 to 46.5</cell><cell>13</cell><cell>5.2</cell><cell>3.1 to 8.8</cell></row><row><cell></cell><cell>(no mBC, BCOC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>≥2 BC+≥1 OC</cell><cell>2090</cell><cell>9.8</cell><cell></cell><cell>833 39.9</cell><cell>37.8 to 42.0</cell><cell cols="2">609 29.1</cell><cell>27.2 to 31.1</cell><cell cols="2">231 11.1</cell><cell>9.8 to 12.5</cell></row><row><cell></cell><cell>(no mBC, BCOC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Total</cell><cell cols="2">5072 23.7</cell><cell cols="2">2111 41.6</cell><cell cols="3">40.3 to 43.0 1624 32.0</cell><cell cols="2">30.7 to 33.3 500</cell><cell>9.9</cell><cell>9.1 to 10.7</cell></row><row><cell>Group 3: mBC</cell><cell>1 mBC+1 BC 51+</cell><cell>97</cell><cell>0.5</cell><cell></cell><cell>16 16.5</cell><cell>10.4 to 25.1</cell><cell>3</cell><cell>3.1</cell><cell>1.1 to 8.7</cell><cell cols="2">13 13.4</cell><cell>8.0 to 21.6</cell></row><row><cell></cell><cell>(no OC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>1 mBC+1 BC 50−</cell><cell>99</cell><cell>0.5</cell><cell></cell><cell>23 23.2</cell><cell>16.0 to 32.5</cell><cell>5</cell><cell>5.1</cell><cell>2.2 to 11.3</cell><cell cols="2">18 18.2</cell><cell>11.8 to 26.9</cell></row><row><cell></cell><cell>(no OC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>1 mBC+≥2 BC</cell><cell>331</cell><cell>1.5</cell><cell></cell><cell>128 38.7</cell><cell>33.6 to 44.0</cell><cell>29</cell><cell>8.8</cell><cell>6.2 to 12.3</cell><cell cols="2">100 30.2</cell><cell>25.5 to 35.4</cell></row><row><cell></cell><cell>(no OC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>≥2 mBC+≥1 BC</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>(no OC)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">on 16 August 2018 by guest. Protected by copyright. http://jmg.bmj.com/ J Med Genet: first published as 10.1136/jmedgenet-2015-103672 on 29 February 2016. Downloaded from</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>The authors thank all the participating women and the German Cancer Aid for supporting GC-HBOC.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Contributors KK: conception of the work, acquisition and interpretation of data, writing of the manuscript, final approval of the version to be published.</s><s>AM and RKS: conception of the work, acquisition and interpretation of data, critical revision of the manuscript for important intellectual content, final approval of the version to be published.</s><s>CE: conception of the work, analysis and interpretation of data, writing of the manuscript, final approval of the version to be published.</s><s>All other authors: acquisition of data, critical revision of the manuscript for important intellectual content, final approval of publication.</s><s>All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</s></p><p><s>Funding Deutsche Krebshilfe (German Cancer Aid), grant no.</s><s>110837.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests None declared.</head><p><s>Patient consent Obtained.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval</head><p><s>The study has been approved by the Institutional Review Boards of each participating centre.</s></p><p><s>Provenance and peer review Not commissioned; externally peer reviewed.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Meta-analysis of BRCA1 and BRCA2 penetrance</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Parmigiani</surname></persName>
		</author>
		<idno type="DOI">10.1200/JCO.2006.09.1066</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1329" to="1333" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Claus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Risch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1002/1097-0142(19940201)73:3&lt;643::AID-CNCR2820730323&gt;3.0.CO;2-5</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="643" to="651" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Patients with double primary tumors in the breast and ovary-clinical characteristics and BRCA1-2 mutations status</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fishman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dekel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chetrit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lerner-Geva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bar-Am</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Beller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ben-Baruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Piura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Struewing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Modan</surname></persName>
		</author>
		<idno type="DOI">10.1006/gyno.2000.5895</idno>
	</analytic>
	<monogr>
		<title level="j">Gynecol Oncol</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="74" to="78" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Zelada-Hedman M, and the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stratton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Narod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldgar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Devilee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lenoir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chang-Claude</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sobol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Teare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Struewing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Arason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Scherneck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Rebbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tonin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Neuhausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Barkardottir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Eyfjord</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Ponder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Gayther</surname></persName>
		</author>
		<idno type="DOI">10.1086/301749</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="676" to="689" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Linkage of early-onset familial breast cancer to chromosome 17q21</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Morrow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Huey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>King</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.2270482</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">250</biblScope>
			<biblScope unit="page" from="1684" to="1689" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Hereditary breast and ovarian cancer: new genes, new treatments, new concepts</title>
		<author>
			<persName><forename type="first">A</forename><surname>Meindl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ditsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rhiem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Schmutzler</surname></persName>
		</author>
		<idno type="DOI">10.3238/arztebl.2011.0323</idno>
	</analytic>
	<monogr>
		<title level="j">Dtsch Arztebl Int</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="323" to="330" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Interdisziplinäre S3-Leitlinie für die Diagnostik</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kreienberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Albert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Follmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kühn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wöckel</surname></persName>
		</author>
		<idno type="DOI">10.1055/s-0033-1355476</idno>
	</analytic>
	<monogr>
		<title level="j">Therapie und Nachsorge des Mammakarzinoms. Senologie-Zeitschrift für Mammadiagnostik und-therapie</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="164" to="192" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer</title>
	</analytic>
	<monogr>
		<title level="j">Familial Breast Cancer</title>
		<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
		<respStmt>
			<orgName>National Collaborating Centre for Cancer</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models</title>
		<author>
			<persName><forename type="first">C</forename><surname>Capalbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ricevuto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vestri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ristori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sidoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Buffone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Adamo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cortesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Marchetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Scambia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tomao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rinaldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ferraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Frati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Screpanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gulino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Giannini</surname></persName>
		</author>
		<idno type="DOI">10.1093/annonc/mdl947</idno>
	</analytic>
	<monogr>
		<title level="j">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="34" to="40" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families</title>
		<author>
			<persName><forename type="first">K</forename><surname>Claes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Poppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Coene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Paepe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Messiaen</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.bjc.6601656</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1244" to="1251" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Frank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Deffenbaugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Reid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hulick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lingenfelter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Gumpper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Scholl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Tavtigian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Pruss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Critchfield</surname></persName>
		</author>
		<idno type="DOI">10.1200/JCO.20.6.1480</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1480" to="1490" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer</title>
		<author>
			<persName><forename type="first">E</forename><surname>Machackova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Foretova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lukesova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vasickova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Navratilova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Coene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pavlu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kosinova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kuklova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Claes</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2407-8-140</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">140</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Hereditary ovarian cancer in Poland</title>
		<author>
			<persName><forename type="first">J</forename><surname>Menkiszak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gronwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gorski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jakubowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Huzarski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Byrski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Foszczynska-Kloda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Haus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Janiszewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Perkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Brozek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Grzybowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zientek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gozdz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kozak-Klonowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Urbanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Miturski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kowalczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pluzanska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Niepsuj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Koc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Szwiec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Drosik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mackiewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lamperska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Strozyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Godlewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stawicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wasko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bebenek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rozmiarek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rzepka-Gorska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Narod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lubinski</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.11338</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="942" to="945" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Risch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mclaughlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bradley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Narod</surname></persName>
		</author>
		<idno type="DOI">10.1093/jnci/djj465</idno>
	</analytic>
	<monogr>
		<title level="j">Canada. J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="1694" to="1706" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers</title>
		<author>
			<persName><forename type="first">N</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schwarz-Boeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pfisterer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Jonat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kiechle</surname></persName>
		</author>
		<idno type="DOI">10.1002/(SICI)1098-1004(199910)14:4&lt;333::AID-HUMU9&gt;3.0.CO;2-C</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mutat</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="333" to="339" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Identification of specific BRCA1 and BRCA2 variants by DHPLC</title>
		<author>
			<persName><forename type="first">E</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pfeifer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bandick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kiechle</surname></persName>
		</author>
		<idno type="DOI">10.1002/1098-1004(200010)16:4&lt;345::AID-HUMU7&gt;3.0.CO;2-%23</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mutat</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="345" to="353" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">ENIGMA Clinical Working Group. BRCA1 and BRCA2 genetic testingpitfalls and recommendations for managing variants of uncertain clinical significance</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Eccles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Monteiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schmutzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Couch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Spurdle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Gómez-García</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1105535</idno>
	</analytic>
	<monogr>
		<title level="j">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2057" to="2065" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">IARC Unclassified Genetic Variants Working Group. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Plon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Eccles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Easton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Foulkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Genuardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Greenblatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Hogervorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hoogerbrugge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Spurdle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Tavtigian</surname></persName>
		</author>
		<idno type="DOI">10.1200/JCO.2005.03.4744</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mutat</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1282" to="1291" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">ENIGMA-evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Spurdle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Healey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Devereau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Hogervorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Monteiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Nathanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Radice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stoppa-Lyonnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tavtigian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wappenschmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Couch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Goldgar</surname></persName>
		</author>
		<idno type="DOI">10.1002/humu.21628</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mutat</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="2" to="7" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Schmutzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rhiem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kiechle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Niederacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Grimm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Speiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schlegelberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Varga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Horvath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Briest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Meindl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Engel</surname></persName>
		</author>
		<idno type="DOI">10.1200/JCO.2014.56.2728</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="2352" to="2361" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gershoni-Baruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dagan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kepten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Robinson</forename><forename type="middle">E</forename></persName>
		</author>
		<idno type="DOI">10.1038/sj.ejhg.5200371</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="833" to="836" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Couch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Deshano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Blackwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Calzone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stopfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Campeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ganguly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rebbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Weber</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJM199705153362002</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">336</biblScope>
			<biblScope unit="page" from="1409" to="1415" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/ or ovaries</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bayliss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lalloo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wallace</surname></persName>
		</author>
		<idno type="DOI">10.1136/jmg.2009.075770</idno>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="561" to="566" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer</title>
		<author>
			<persName><forename type="first">D</forename><surname>Steinmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bremer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rades</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Skawran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Siebrands</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Karstens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dork</surname></persName>
		</author>
		<idno type="DOI">10.1054/bjoc.2001.2016</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="850" to="858" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Fitzgerald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Krainer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hoover</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Neil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Unsal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Silva-Arrieto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Finkelstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Beer-Romero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Englert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sgroi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Younger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Garber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Duda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Mayzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Isselbacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Friend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Haber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="DOI">10.1056/NEJM199601183340302</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">334</biblScope>
			<biblScope unit="page" from="143" to="149" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">BRCA1 mutations in a population-based sample of young women with breast cancer</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Langston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Malone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Daling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Ostrander</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJM199601183340301</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">334</biblScope>
			<biblScope unit="page" from="137" to="142" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Couch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Hart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Toland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Miron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Godwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Pankratz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Olswold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Slettedahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hallberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Guidugli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Davila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Beckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Janni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Ekici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Slamon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Konstantopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fostira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vratimos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fountzilas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Pelttari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Tapper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Durcan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Cross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pilarski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Shapiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Klemp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Garber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Brauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ambrosone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nevanlinna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yannoukakos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Slager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Vachon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Eccles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Fasching</surname></persName>
		</author>
		<idno type="DOI">10.1200/JCO.2014.57.1414</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="304" to="311" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">BayesMendel: an R environment for Mendelian risk prediction</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Broman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Katki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Parmigiani</surname></persName>
		</author>
		<idno type="DOI">10.2202/1544-6115.1063</idno>
	</analytic>
	<monogr>
		<title level="j">Stat Appl Genet Mol Biol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e21</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Kuchenbaecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mavaddat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.2013.730</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="535" to="545" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">A breast cancer prediction model incorporating familial and personal risk factors</title>
		<author>
			<persName><forename type="first">J</forename><surname>Tyrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Duffy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cuzick</surname></persName>
		</author>
		<idno type="DOI">10.1002/sim.1668</idno>
	</analytic>
	<monogr>
		<title level="j">Stat Med</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1111" to="1130" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium</title>
		<author>
			<persName><forename type="first">C</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kuchenbacker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zachariae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rhiem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Meindl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rahner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dikow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Plendl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Debatin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Grimm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gadzicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Flottmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Horvath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Schrock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Stock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schafer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Schwaab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kartsonaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mavaddat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schlegelberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schmutzler</surname></persName>
		</author>
		<idno type="DOI">10.1136/jmedgenet-2012-101415</idno>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="360" to="367" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>German Consortium for Hereditary Breast and Ovarian Cancer</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Pathology of ovarian cancers in BRCA1 and BRCA2 carriers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Lakhani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Manek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Penault-Llorca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Flanagan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Arnout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Merrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mcguffog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Steele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Devilee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Klijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Meijers-Heijboer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Radice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pilotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nevanlinna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Butzow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sobol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jacquemier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Lyonet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Neuhausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Winqvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Bignon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Monti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lenoir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Seitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Hamman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pharoah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ponder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.CCR-1029-3</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="2473" to="2481" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Ovarian carcinoma pathology and genetics: recent advances</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Gilks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Prat</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.humpath.2009.04.017</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1213" to="1223" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Hereditary ovarian cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Prat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ribe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gallardo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.humpath.2005.06.006</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="861" to="870" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">K</forename><surname>Kast</surname></persName>
		</author>
		<idno type="DOI">10.1136/jmedgenet-2015-103672</idno>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="465" to="471" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
